SCHEMBL30837859

SCHEMBL30837859

COc1cc(Cn2c(=O)c3cc(OC(CF)CF)ccc3n(C3CCN(C=O)CC3)c2=O)ccc1OCC(=O)N1CCCCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDE7A Q13946 10/20 1.00
▸ PDE7B Q9NP56 5/20 1.00
▸ PDE8A O60658 3/20 1.00
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HTT P42858 2/20 0.37
▸ POLB P06746 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA2B P29275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL100957 1.00 PDE7A (1.00) PDE7APDE7BPDE8AMEN1KMT2A
SCHEMBL30837842 0.92 PDE7A (0.84) PDE7APDE7BPDE8AMEN1KMT2A
SCHEMBL100106 0.92 PDE7A (0.84) PDE7APDE7BPDE8AMEN1KMT2A
SCHEMBL30837881 0.90 PDE7A (1.00) PDE7APDE7BPDE8AMEN1KMT2A
SCHEMBL100704 0.90 PDE7A (1.00) PDE7APDE7BPDE8AMEN1KMT2A
SCHEMBL30837890 0.89 PDE7A (0.83) PDE7APDE7BPDE8AMEN1KMT2A
SCHEMBL100225 0.89 PDE7A (0.83) PDE7APDE7BPDE8AMEN1KMT2A
SCHEMBL100171 0.89 PDE7A (0.90) PDE7APDE7BPDE8AMEN1KMT2A
SCHEMBL30837841 0.89 PDE7A (0.93) PDE7APDE7BPDE8AMEN1KMT2A
SCHEMBL100239 0.89 PDE7A (0.93) PDE7APDE7BPDE8AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572765-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE Mitodicure GmbH (DE) 2025-06-25 — — EP disclosed
WO-2024038089-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE MITODICURE GMBH (DE) 2024-02-22 — — WO disclosed
Send feedback